Intrinsic Value of S&P & Nasdaq Contact Us

DexCom, Inc. DXCM NASDAQ

NASDAQ Global Select • Healthcare • Medical - Devices • US • USD

SharesGrow Score
82/100
7/7 Pass
SharesGrow Intrinsic Value
$98.26
+56.1%
Analyst Price Target
$85.82
+36.3%
SharesGrow 7-Criteria Score All 7 criteria scored · income-related highlighted on this page

DexCom, Inc. (DXCM) has shown strong revenue growth over the past 3 years, expanding from $2.9B to $4.7B (average +17.1%/yr). Net income reached $836M, reflecting exceptional earnings expansion at +36.8%/yr on average. The net profit margin is 17.9%, which is high. The company has maintained profitability in all 4 of the past 4 years, demonstrating a consistent earnings track record. The gross margin is 60.1% (high), with a -4.6pp trend over the period. With a $25B market cap and MOAT composite score of 71/100, the company has a strong competitive position.

Criteria proven by this page:

  • GROWTH (90/100, Pass) — proving strong growth momentum
  • PAST (100/100, Pass) — proving consistent earnings. Looking at the full 26-year history, the company was profitable in 7 of 26 years — a mixed long-term record
  • INCOME (70/100, Pass) — proves strong profitability and pricing power
  • MOAT (71/100, Pass) — strong gross margins and market scale prove a durable competitive advantage

Overall SharesGrow Score: 82/100 with 7/7 criteria passed.

82/100
SG Score
View full scorecard →
VALUE
69/100
Price-to-Earnings & upside
→ IV page
FUTURE
94/100
Analyst consensus
→ Forecast
PAST
100/100
4/4 yrs profit
EPS $2.09
Proven by this page
HEALTH
83/100
Debt-to-Equity & liquidity
→ Health
MOAT
71/100
Score: 71/100
GM 60.1% (-4.6pp)
Proven by this page
GROWTH
90/100
Rev +17.1%/yr
NI +36.8%/yr
Proven by this page
INCOME
70/100
Margin 17.9%
$4.7B
Proven by this page
DexCom, Inc. Earnings and Revenue History
Analyst Forecast →
Revenue  Actual & Estimate
Earnings & Profit Margin  Actual & Estimate
Metric TTM FY2025 FY2024 FY2023 FY2022
Revenue $4.66B$4.66B$4.03B$3.62B$2.91B
Gross Profit $2.8B$2.8B$2.47B$2.29B$1.88B
Gross Margin 60.1%60.1%61.1%63.2%64.7%
Operating Income $911.8M$911.8M$600M$597.7M$391.2M
Net Income $836.3M$836.3M$576.2M$541.5M$341.2M
Net Margin 17.9%17.9%14.3%14.9%11.7%
EPS (Diluted) $2.09$2.09$1.42$1.30$0.80
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message